S.No |
Title |
1 |
Randomized Placebo Controlled Trial of Valproate and levocarnitine in Children with Spinal Muscular Atrophy aged 2-15 years (Follow up completed: result awaited) |
2 |
Blood heavy metal levels and quantitative EEG in children with Autism- A cross sectional study |
3 |
Validation and Indian Adaptation of the adapted ASQ-3 (Ages and Stages Questionnaire) as a developmental screening tool as compared to reference standard tool (DASII- Developmental Assessment Scale for Indian Infants) in Indian children 2 to 24 months of age |
4 |
Multi center randomized double blind placebo controlled trial to evaluate the effects of intra erythrocyte dexamethasone sodium phosphate on neurological symptoms in patients with Ataxia Telangiectasia |
5 |
A Randomized , double blind placebo controlled six month study to evaluate the efficacy, safety and tolerability of Sarizotan in patients with Rett syndrome with respiratory symptoms |
6 |
Development and Validation of a scalable mobile platform for screening of developmental neuropsychiatric disorders in low resource settings: START-Screening Tools for Autism Risk using Technology: Study site |
7 |
Serum matrix metalloproteinase- 9: a potential biomarker for predicting calcification and epilepsy in Neurocysticercosis; a longitudinal observational study |
8 |
The effect of structured weight bearing exercise program on BMD in children with cerebral palsy |
9 |
Telephone based follow-up of children with epilepsy aged 4 months to 18yrs: comparison of accuracy between a specialty nurse and a DM Pediatric Neurology resident to identify critical clinical events requiring face to face evaluation |
10 |
Validation of END-IT score in children aged 1 month to 14 years with convulsive status epilepticus |
11 |
Health related quality of life of children (aged 3 to 12 yrs) with autism spectrum disorder (fulfilling DSM-5 criteria) |
12 |
Use of ‘My Whole Child; Child Health and Development Interactive System’, a web based platform for holistic evaluation and management of Indian children and adolescents upto 18 years of age; a tertiary centre pilot study |
13 |
Effect of weighted compression Vest on hyperactivity of children aged 6-9 years diagnosed autism by DSM-5 |
14 |
Impact of advanced paternal age and poor lifestyle on sperm epigenome: possible etiology in Autism Spectrum Disorder |
15 |
The pathways to cure for Autism Spectrum Disorders |
16 |
Understanding and improving the nonverbal biomarkers of object perception in autistic subjects |
17 |
Imaging of Infantile Brachial Plexopathy |
18 |
Cortical sources and connectivity in Autism spectrum disorder: A QEEG study |
19 |
Comparison of serum 25 Hydroxy viramin D and trace elements levels between 6-18 year old ADHD and typically developing children and adolescents and their correlation with symptom severity and comorbidities: Analytical cross sectional study |
20 |
Developing a tool to identify the early signs of Autism Spectrum Disorder in children 1-18 months of age; an observational study |
21 |
Comparing the efficacy of virtual reality therapy with modified constraint induced movement therapy versus modified constraint induced movement therapy alone, for children with hemiparetic cerebral palsy aged ≥ 5-18 years- An open labeled, randomized controlled, parallel design, superiority trial |